Synthesis of hepatitis B surface and core antigens in E. coli

No abstract is available for this paper.

• Publication year

  1981

• Venue

  Nature

• Publication date

  1981-06-11

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1038/291503A0PMID 6262658
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hepatitis B vaccine: demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States.

  1980cited by this paper
• Biosynthesis of hepatitis B virus surface antigen in Escherichia coli

  1980cited by this paper
• Recovery of DNA from gels.

  1980cited by this paper
• The construction and characterisation of plasmid vectors suitable for the expression of all DNA phases under the control of the E. coli tryptophan promoter

  1980cited by this paper
• A functional hybrid ribosome binding site in tryptophan operon messenger RNA of Escherichia coli.

  1980cited by this paper
• Plasmid vectors containing the tryptophan operon promoter suitable for efficient regulated expression of foreign genes.

  1980cited by this paper
• Isolation and characterization of two proteins possessing Hpa II methylase activity.

  1980cited by this paper
• Antigenic conversion from HBcAg to HBeAg by degradation of hepatitis B core particles.

  1980cited by this paper
• THE NUCLEOTIDE SEQUENCE OF THE HEPATITIS B VIRAL GENOME AND THE IDENTIFICATION OF THE MAJOR VIRAL GENES

  1980cited by this paper
• [46] Recovery of DNA from gels

  1980cited by this paper
• Direct expression in Escherichia coli of a DNA sequence coding for human growth hormone

  1979cited by this paper
• Synthesis of simian virus 40 t antigen in Escherichia coli.

  1979cited by this paper
• A rapid alkaline extraction procedure for screening recombinant plasmid DNA.

  1979cited by this paper
• Demonstration of hepatitis B e antigen in the core of Dane particles.

  1979cited by this paper
• Protein degradation is stimulated by ATP in extracts of Escherichia coli.

  1979cited by this paper
• Human growth hormone: complementary DNA cloning and expression in bacteria.

  1979cited by this paper
• Role of hepatitis B virus in primary liver cancer.

  1979cited by this paper
• Hepatitis B virus genes and their expression in E. coli

  1979cited by this paper
• Nucleotide sequence of the hepatitis B virus genome (subtype ayw) cloned in E. coli

  1979cited by this paper
• Expression in Escherichia coli of hepatitis B virus DNA sequences cloned in plasmid pBR322

  1979cited by this paper
• Cellular and humoral immunity in guinea pigs to two major polypeptides derived from hepatitis B surface antigen.

  1978cited by this paper
• Chicken ovalbumin is synthesized and secreted by Escherichia coli.

  1978cited by this paper
• Phenotypic expression in E. coli of a DNA sequence coding for mouse dihydrofolate reductase

  1978cited by this paper
• Translation of the leader region of the Escherichia coli tryptophan operon

  1978cited by this paper
• Comparison of the nucleotide sequences of the initial transcribed regions of the tryptophan operons of Escherichia coli and Salmonella typhimurium.

  1978cited by this paper
• Rat insulin genes: construction of plasmids containing the coding sequences.

  1977cited by this paper
• A new method for sequencing DNA.

  1977cited by this paper
• Plasmid detection and sizing in single colony lysates.

  1977cited by this paper
• Nucleotide sequence of region preceding trp mRNA initiation site and its role in promoter and operator function.

  1976cited by this paper
• Terminal labeling and addition of homopolymer tracts to duplex DNA fragments by terminal deoxynucleotidyl transferase.

  1976cited by this paper
• Chain length determination of small double- and single-stranded DNA molecules by polyacrylamide gel electrophoresis.

  1975cited by this paper
• Determinant of cistron specificity in bacterial ribosomes

  1975cited by this paper
• Prevalence of Hepatitis B Virus Antigen As Revealed by Direct Radioimmune Assay with 125I-Antibody

  1972cited by this paper
• Prevalence of hepatitis B virus antigen as revealed by direct radioimmune assay with 125 I-antibody.

  1972cited by this paper
• Experiments in molecular genetics

  1972cited by this paper
• Nonchromosomal antibiotic resistance in bacteria: genetic transformation of Escherichia coli by R-factor DNA.

  1972cited by this paper
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

  1970cited by this paper
• Dynamics of synthesis, translation, and degradation of trp operon messenger RNA in E. coli.

  1969cited by this paper
• A complementation analysis of the restriction and modification of DNA in Escherichia coli.

  1969cited by this paper

• Heterologous Expression of Recombinant Proteins and Their Derivatives Used as Carriers for Conjugate Vaccines

  2023cites this paper
• Studies on HBcAg-rBlo t 5-21 Fusion Protein Vaccine That Alleviates Blomia tropicalis Airway Inflammation

  2022cites this paper
• Hepatitis B core-based virus-like particles: A platform for vaccine development in plants

  2021cites this paper
• Plant-derived VLP: a worthy platform to produce vaccine against SARS-CoV-2

  2021cites this paper
• Bioengineering of Virus-Like Particles as Dynamic Nanocarriers for In Vivo Delivery and Targeting to Solid Tumours.

  2021cites this paper
• Platforms for Production of Protein-Based Vaccines: From Classical to Next-Generation Strategies

  2021cites this paper
• Dual-Antigen-Loaded Hepatitis B Virus Core Antigen Virus-like Particles Stimulate Efficient Immunotherapy Against Melanoma.

  2020cites this paper
• Unique product quality considerations in vaccine development, registration and new program implementation in Malaysia

  2019cites this paper
• Hepatitis B Virus Infection: Overview.

  2019cites this paper
• Construction of Multifunctional Fe3O4-MTX@HBc Nanoparticles for MR Imaging and Photothermal Therapy/Chemotherapy

  2018cites this paper
• Early Recombinant Protein Therapeutics

  2017cites this paper
• Engineering hepatitis B virus core particles for targeting HER2 receptors in vitro and in vivo

  2017cites this paper
• Effects of mRNA secondary structure on the expression of HEV ORF2 proteins in Escherichia coli

  2017cites this paper
• Construction and Immunological Evaluation of CpG-Au@HBc Virus-Like Nanoparticles as a Potential Vaccine

  2016cites this paper
• Vaccine technologies: From whole organisms to rationally designed protein assemblies

  2016cites this paper
• Efficient isolation of genes by using

  2016cites this paper
• History and Potential of Hepatitis B Virus Core as a VLP Vaccine Platform

  2015cites this paper
• Production of Hepatitis B Vaccines by Beneficial Microorganisms

  2015cites this paper
• The application of virus-like particles as vaccines and biological vehicles

  2015cites this paper
• Construction, Expression and Characterization of Multi Cassettes Encoding Indonesian Small Hepatitis B Surface Antigen (s-HBsAg) in Methylotropic Yeast Pichia pastoris

  2015cites this paper
• Fungal Expression Systems for Vaccine Production

  2014cites this paper
• A VLP Library of C-Terminally Truncated Hepatitis B Core Proteins: Correlation of RNA Encapsidation with a Th1/Th2 Switch in the Immune Responses of Mice

  2013cites this paper
• Plant-derived virus-like particles as vaccines

  2013cites this paper
• Virus‐Like Particle Bioprocessing

  2012cites this paper
• Expression and purification of hepatitis B surface antigen S from Escherichia coli; a new simple method

  2012cites this paper
• Virus-like particle production with yeast: ultrastructural and immunocytochemical insights into Pichia pastoris producing high levels of the Hepatitis B surface antigen

  2011cites this paper
• Using Site-directed Mutagenesis to Study Carboxypeptidase A: the Work of William J. Rutter

  2010cites this paper
• Recombinant proteins and genomics in cancer therapy

  2009cites this paper
• Expression of HBsAg and preS2-S protein in different yeast based system: a comparative analysis.

  2009cites this paper
• Association of hepatitis Be antigen (HBeAg) with the core of the hepatitis B virus (HBcAg).

  2008cites this paper
• Gewinnung von Peptidhormonen durch DNA‐Rekombination

  2006cites this paper
• Vaccination against viral hepatitis

  2005cites this paper
• Viral vaccines: The use of currently available products and future developments

  2005cites this paper
• Purification of the recombinant hepatitis B virus core antigen (rHBcAg) produced in the yeast Saccharomyces cerevisiae and comparative observation of its particles by transmission electron microscopy (TEM) and atomic force microscopy (AFM).

  2004cites this paper
• EXPRESSION OF PROTEINS IN ESCHERICHIA COLI UNIT 16 . 1 Overview of Protein Expression in E . coli

  2003cites this paper
• 8 Artificial Genes for Chimeric Virus-Like Particles

  2003cites this paper
• Combining science and business: from recombinant DNA to vaccines against hepatitis B virus

  2001cites this paper
• Purification of recombinant HBc antigen expressed in Escherichia coli and Pichia pastoris: comparison of size-exclusion chromatography and ultracentrifugation.

  2001cites this paper
• Effect of copy number on the expression levels of hepatitis B surface antigen in the methylotrophic yeast Pichia pastoris.

  2001cites this paper
• HBV Core Particles as a Carrier for B Cell/T Cell Epitopes

  2001cites this paper
• Overexpression of human testis antigens in Escherichia coli host cells is influenced by site of expression and the induction temperature

  1999cites this paper
• Core particles of hepatitis B virus as carrier for foreign epitopes.

  1998cites this paper
• Recombinant Organisms as Source of Cancer Biotherapeutics

  1998cites this paper
• Localization of the amino terminus of the hepatitis B virus core antigen within the core particle.

  1997cites this paper
• Interactions between the surface and core antigens of Hepatitis B virus

  1997cites this paper
• Assembly of hepatitis delta virus-like empty particles in yeast.

  1997cites this paper
• A hydrophobic heptad repeat of the core protein of woodchuck hepatitis virus is required for capsid assembly

  1996cites this paper
• Chimaera and its modern virus-like descendants.

  1996cites this paper
• Assembly and antigenicity of hepatitis B virus core particles.

  1995cites this paper
• Deletion or alteration of hydrophobic amino acids at the first and the third transmembrane domains of hepatitis B surface antigen enhances its production in Escherichia coli.

  1995cites this paper
• Hepatitis B virus core particles as epitope carriers.

  1995cites this paper
• A protease-sensitive hinge linking the two domains of the hepatitis B virus core protein is exposed on the viral capsid surface

  1994cites this paper
• Immunoaffinity purification of recombinant hepatitis B surface antigen from yeast using a monoclonal antibody.

  1994cites this paper
• A eukaryotic cytosolic chaperonin is associated with a high molecular weight intermediate in the assembly of hepatitis B virus capsid, a multimeric particle

  1994cites this paper
• Identification of hepatitis B virus core protein regions exposed or internalized at the surface of HBcAg particles by scanning with monoclonal antibodies.

  1994cites this paper
• Improvement of cloned alpha-amylase gene expression in fed-batch culture of recombinant Saccharomyces cerevisiae by regulating both glucose and ethanol concentrations using a fuzzy controller.

  1994cites this paper
• Three-dimensional structure of hepatitis B virus core particles determined by electron cryomicroscopy.

  1994cites this paper
• Improvement of cloned α‐amylase gene expression in fed‐batch culture of recombinant Saccharomyces cerevisiae by regulating both glucose and ethanol concentrations using a fuzzy controller

  1994cites this paper
• Prediction of a putative fusion peptide in the S protein of hepatitis B virus.

  1994cites this paper
• Production and simple purification of a protein encoded by part of the gag gene of HIV-1 in the Escherichia coli HB101F+ expression system inducible by lactose and isopropyl-beta-D-thiogalactopyranoside.

  1994cites this paper
• Mutations that affect the structure and interactions of the core antigen of hepatitis B virus

  1993cites this paper
• A micromolar pool of antigenically distinct precursors is required to initiate cooperative assembly of hepatitis B virus capsids in Xenopus oocytes

  1993cites this paper
• Comparison of three different promoter systems for secretory α‐amylase production in fed‐batch cultures of recombinant Saccharomyces cerevisiae

  1993cites this paper
• The recovery of the hepatitis B virus surface antigen (HBsAg) from a recombinant P. pastoris strain disruption and precipitation studies

  1993cites this paper
• Stability governs the apparent expression of "particulate" hepatitis B e antigen by mutant hepatitis B virus core particles.

  1993cites this paper
• Adsorption–desorption of recombinant hepatitis B surface antigen (r‐HBsAg) from P. pastoris on a diatomaceous earth matrix: Optimization of parameters for purification

  1993cites this paper
• Comparison of three different promoter systems for secretory alpha-amylase production in fed-batch cultures of recombinant Saccharomyces cerevisiae.

  1993cites this paper
• Gene isolation with lambda gt11 system.

  1991cites this paper
• Heterologous Gene Expression in Hansenula Polymorpha: Efficient Secretion of Glucoamylase

  1991cites this paper
• Optimization of the expression of a foreign gene from galactose-inducible promoter in a recombinant yeast

  1991cites this paper
• [15] Gene isolation with λgt11 system

  1991cites this paper
• Expression of pre‐S2 region of hepatitis B surface antigen in Escherichia coli

  1990cites this paper
• Synthesis of hepatitis B virus core antigen polypeptide in E. coli using pKK223-3 plasmid, a vector for expression, with tac promoter.

  1990cites this paper
• Development and production aspects of a recombinant yeast-derived hepatitis B vaccine.

  1990cites this paper
• Expression Using Vectors with Phage λ Regulatory Sequences

  1990cites this paper
• Effect of the N-terminal hydrophobic sequence of hepatitis B virus surface antigen on the folding and assembly of hybrid beta-galactosidase in Escherichia coli.

  1990cites this paper
• Antigens and Adjuvants for a New Generation of Vaccines

  1989cites this paper
• The maximum rate of gene expression is dependent on the downstream context of unfavourable codons.

  1989cites this paper
• The development of biosynthetic vaccines.

  1989cites this paper
• Expression of hepatitis B virus large envelope protein in Escherichia coli and Saccharomyces cerevisiae.

  1989cites this paper
• Crystallizable HIV-1 protease derived from expression of the viral pol gene in Escherichia coli.

  1989cites this paper
• A recombinant hepatitis B core antigen polypeptide with the protamine-like domain deleted self-assembles into capsid particles but fails to bind nucleic acids

  1989cites this paper
• Expression vectors employing lambda-, trp-, lac-, and lpp-derived promoters.

  1988cites this paper
• Production of the human immunoglobulin γ1 chain constant region polypeptides in Escherichia coli

  1988cites this paper
• A survey of vectors for regulating expression of cloned DNA in E. coli.

  1988cites this paper
• [Expression in Escherichia coli of DNA coding for human tumor necrosis factor].

  1988cites this paper
• [Genetically engineered mutants of the core antigen of the human hepatitis B virus preserving the ability for native self-assembly].

  1988cites this paper
• [Vaccines against hepatitis viruses].

  1988cites this paper
• Synthesis and expression in Escherichia coli of the gene encoding monocyte-derived neutrophil-activating factor: biological equivalence between natural and recombinant neutrophil-activating factor.

  1988cites this paper
• Recombinant versus plasma-derived hepatitis B vaccines: issues of safety, immunogenicity and cost-effectiveness.

  1988cites this paper
• Human C5a anaphylatoxin: gene synthesis, expression, and recovery of biologically active material from Escherichia coli.

  1988cites this paper
• Plant phosphoglucose isomerase genes lack introns and are expressed in Escherichia coli

  1988cites this paper
• Formation of Soluble Recombinant Proteins in Escherichia Coli is Favored by Lower Growth Temperature

  1988cites this paper
• Expression of the human alpha-galactosidase A in Escherichia coli K-12.

  1987cites this paper
• Construction and stability of a sixfold repeated artificial gene.

  1987cites this paper
• Vaccine Technology: Developmental Strategies

  1987cites this paper
• The Leeuwenhoek Lecture, 1985 - A molecular biologist’s view of viral hepatitis

  1987cites this paper
• Specificity of enzyme immunoassay for hepatitis B core antibody used in screening blood donors

  1987cites this paper
• Construction and characterization of a Saccharomyces cerevisiae strain (RIT4376) expressing hepatitis B surface antigen.

  1987cites this paper
• Recombinant Hepatitis B Virus Surface Antigen P31 Accumulates as Particles in Saccharomyces Cerevisiae

  1987cites this paper